Abstract. Concerted efforts from national and international partners have scaled up malaria control interventions, including insecticide-treated nets, indoor residual spraying, diagnostics, prompt and effective treatment of malaria cases, and intermittent preventive treatment during pregnancy in sub-Saharan Africa (SSA). This scale-up warrants an assessment of its health impact to guide future efforts and investments; however, measuring malaria-specific mortality and the overall impact of malaria control interventions remains challenging. In 2007, Roll Back Malaria's Monitoring and Evaluation Reference Group proposed a theoretical framework for evaluating the impact of full-coverage malaria control interventions on morbidity and mortality in high-burden SSA countries. Recently, several evaluations have contributed new ideas and lessons to strengthen this plausibility design. This paper harnesses that new evaluation experience to expand the framework, with additional features, such as stratification, to examine subgroups most likely to experience improvement if control programs are working; the use of a national platform framework; and analysis of complete birth histories from national household surveys. The refined framework has shown that, despite persisting data challenges, combining multiple sources of data, considering potential contributions from both fundamental and proximate contextual factors, and conducting subnational analyses allows identification of the plausible contributions of malaria control interventions on malaria morbidity and mortality.
INTRODUCTION
Malaria remains a public heath challenge in sub-Saharan Africa (SSA) despite concerted efforts from national and international partners to scale up effective malaria control interventions, such as insecticide-treated nets (ITNs), indoor residual spraying (IRS), diagnostics, prompt and effective treatment of malaria cases, and intermittent preventive treatment during pregnancy (IPTp). The World Health Organization (WHO) estimates that between 2001 and 2013, 670 million fewer cases and 4.3 million fewer malaria deaths occurred globally than would have occurred if incidence and mortality rates had remained unchanged since 2000. Of the estimated 4.3 million deaths averted between 2001 and 2013, 3.9 million, or 92%, were among children under 5 years of age in SSA. 1 Global investments in malaria control and elimination efforts exceeded USD $2.7 billion in 2013, 1 resulting in a strong desire from funding partners and national malaria control programs for rigorous evaluations of scaling up malaria control interventions to quantify the impact on malaria-associated morbidity and mortality. Several challenges complicate this task. First, nearly all malaria control interventions are either implemented as national coverage programs or targeted to high-transmission risk areas. 2, 3 In such cases, a contemporaneous control group, or counterfactual, is often unavailable, hindering direct causal inference between exposure to malaria control interventions and any observed changes in malaria health outcomes. 4 Second, data on malaria morbidity, mortality, and transmission are often unavailable at the required scale or are inappropriate for use in analysis. Third, other factors can affect malaria health outcomes, such as additional maternal and child health interventions, socioeconomic conditions, and environmental factors, but they may not be well documented. Fourth, it is difficult to define an evaluation's baseline, midline, and endline, 4, 5 so that intervention scale-up timing and coverage level obtained must be carefully considered to ensure a complete assessment. Finally, the efficacy of malaria interventions is already proven, unlike other development fields, the evaluation question is more about program implementation of proven interventions and the effectiveness.
A rigorous and valid evaluation design must address these constraints; therefore, in 2007 Roll Back Malaria's (RBM) Monitoring and Evaluation Reference Group (MERG) proposed a framework for evaluating full-coverage malaria control intervention impacts on morbidity and mortality in high-burden SSA countries, 6 which was the first attempt to propose an evaluation method that fits malaria-control intervention. That framework, however, was theoretical and not yet implemented to uncover potential challenges.
Because standard academic definitions of evaluation attribute change in impact measures directly to program interventions, the framework is not, in the strictest sense, an impact evaluation. It is more about plausibility design as opposed to adequacy and probability design. 7 In this article, impact evaluation refers to the potential contribution of a package of malaria control interventions, which could be national malaria programs, to change malaria morbidity and mortality (Table 1 , definition of key terms).
This article expands the RBM/MERG framework and highlights some of the challenges in applying this theoretical framework. In addition, we take the RBM/MERG framework further by including secondary analyses to more rigorously examine causal inference. These analyses include stratification, use of a national-platform analytic framework, and analysis of birth history data from national household surveys to assess child survival. Our framework takes into account new program data from intervention scale-ups since 2007 and new evaluation experience. 8, 9 This updated framework may be useful to stakeholders that are responsible for implementing and evaluating malaria intervention impacts, such as ministries of health, national malaria control programs, and development partners that support malaria control efforts.
MATERIALS AND METHODS
Evaluation objectives. The main objectives of an malaria control intervention impact evaluations are to 1) measure the degree of implementation success and outcomes compared with targets set in the national strategic plan, 2) assess trends in malaria-related morbidity and all-cause under-five mortality as a complementary malaria impact indicator, and 3) assess the plausible attribution of the malaria control intervention scale-up on malaria-related morbidity and all-cause under-five mortality, and also account for contextual factors, such as determinants of malaria transmission and child survival.
Following are the specific evaluation questions:
c Was the scale-up sufficient enough to affect nationallevel malaria-specific morbidity and all-cause under-five mortality? c Was sustained coverage of malaria control intervention achieved? Was the coverage equitable across socioeconomic groups? c Was the increase in coverage of interventions associated with impact on national all-cause under-five mortality? c Was impact highest among those risk groups with the greatest potential to benefit from exposure to the interventions? And was the impact equitable across socioeconomic groups? c Can other plausible explanations of the observed change in national all-cause under-five mortality be excluded?
Evaluation design. An experimental study design is assumed to be the gold standard for assessing efficacy of new interventions. 5 Using such a design to evaluate a package of malaria control interventions is challenging for several reasons, the foremost being a lack of randomization to designate an intervention group and a control group, or a counterfactual. Where malaria control interventions are scaled up or intensified staggered over time, it may be possible to use a step-wedge quasi-experimental evaluation design. 7, 10, 11 However, the step-wedge design is subject to variations among wedges 6 regarding geographical settings, population, or transmission patterns. The design is also subject to contamination among wedges, such as the higher burden areas may receive interventions first, compared with those with lower burden, and randomizing between the two settings poses significant ethical challenges. Also, limited subnationallevel longitudinal, population-based data on the coverage of malaria control interventions and health outcomes precludes evaluation designs, such as a national platform approach, to assess a dose-response relationship between coverage and outcomes. 11 To address these constraints, a prepost reflexive control study design, also known as the ecological or plausibility study design, for evaluating the effectiveness of nationalcoverage malaria control interventions has been proposed. 6, 7, 11 The plausibility study design contends that if the interventions have already proven efficacious on malaria outcomes, then it is plausible that their scale-up could have contributed to or driven the observed reductions in malaria burden, unless other contextual factors and nonmalaria related interventions are unlikely to explain all of these reductions in burden. For example, randomized controlled trials have established protective efficacy of ITN use on the incidence of malaria illness and all-cause under-five mortality; [12] [13] [14] therefore, increasing coverage of ITNs use should reduce malaria morbidity and mortality over a time period consistent with the impacts established in the trials. The plausibility design is strengthened if malaria burden baseline levels can be established before intervention scale-up, with the counterfactual being that pre-scale-up malaria trends would have continued in the absence of the interventions. Thus, over time, the intervention group serves as its own comparison group ( Figure 1 ).
The strongest plausibility assessment can be made when there is evidence of a statistically significant increase in intervention coverage and use that is substantial enough to achieve a realistically proportional reduction in malaria-related morbidity and all-cause under-five mortality within the time frame expected ( Table 2 ). The relationships between increasing coverage and use and reducing morbidity and mortality; however, are not linear. The plausibility assessment must also document contextual factors, both health-related and not, that may affect changes in malaria-related morbidity and child mortality.
This plausibility assessment assumes evaluators can 1) reliably measure changes in malaria intervention coverage, malaria health outcomes, and contextual factors over time; 2) determine that increases in malaria intervention coverage adequately preceded changes in malaria health outcomes; and 3) record whether health impact was highest among specific risk groups with the greatest potential to benefit from exposure to the interventions. The plausibility design should take into consideration all of the Bradford Hill criteria for causality, as outlined in Table 3 . FIGURE 1. Plausibility study design framework for assessing malaria control intervention impact on malaria morbidity and all-cause child mortality. ANC = antenatal care; EIR = entomological inoculation rate; EPI = extended program for immunization; ITN = insecticide-treated net; IRS = indoor residual spraying; IPTp = intermittent preventive treatment; GDP = gross domestic product; MCM = malaria case management; Vit = vitamin; PMTCT = prevention of mother to child transmission. This figure appears in color at www.ajtmh.org.
FRAMEWORK FOR EVALUATING THE IMPACT OF MALARIA CONTROL INTERVENTIONS
Evaluation timing. Strategically timing an impact evaluation is important in achieving the most effective, informative results. Stakeholders should be enlisted to develop criteria to define the evaluation baseline, midline, and end line, based on when malaria control intervention implementation occurred and the availability of data points. 6 When possible, baseline outcome measures should be established well before malaria control intervention scale-up because under-five mortality estimates from household surveys reflect the situation an average of 2.5 years preceding the survey. Figure 2 illustrates a sample evaluation timeframe, including intervention milestones and timing of data sources.
There is no simple, direct way to determine when an impact evaluation becomes appropriate-the exact time point after malaria control intervention scale-up begins or the level of intervention coverage. If the scale-up is still in the early stages, coverage levels may still be too low, and an impact evaluation may not be recommended; however, it is difficult to state a threshold for when national-level impact is likely to become measurable. Conducting an evaluation takes substantial planning and inputs, as illustrated in the process of RBM impact evaluations led by the President's Malaria Initiative (PMI). 15 A program performance review that assesses program implementation success may be suitable when impact evaluations are not. 16 Evaluation indicators. Changes in coverage of malaria control interventions. MERG issued a set of primary population-level indicators to measure changes in coverage of key malaria control interventions. 17 These indicators measure how well malaria control interventions are being Data might not be as specific as required All-cause under-five mortality is a sensitive, specific, and time-sensitive proxy for changes in malaria-specific mortality in highly endemic countries 
and subnational estimates for intervention coverage indicators. Further coverage data may come from health management information systems (HMIS), Health and Demographic Surveillance Systems, 18 or special surveys conducted for specific projects, such as post-campaign long-lasting insecticidal nets coverage surveys. Other malaria program data, such as timing and quantity of malaria commodity distribution, might also help understand intervention coverage. Data from these sources, with the potential to contribute to measuring and understanding coverage, should be evaluated for rigor and incorporated in the analysis when appropriate, considering scope, sampling, and the data collection method.
Malaria morbidity, mortality, and transmission indicators.
Indicators of key malaria outcomes are used to assess how the burden of malaria has changed over time, presumably as a result of malaria control intervention scale-up. Examples of these outcomes include malaria morbidity, determined by prevalence of malaria antigens or parasites; density of parasitemia (parasites/μL) or severe anemia (< 8 g/dL) in children under 5 years of age, 19 or all-cause under-five mortality. When data are available, an outcome indicator can be determined from malaria transmission intensity, measured through malaria infection incidence rates, or force of infection, or the entomological inoculation rate. 20, 21 Health Management and Information Systems have the potential to provide malaria-specific morbidity and mortality data, when proper diagnosis and medical certification of cause of death are available. The quality of the data depends on consistent, appropriate use of diagnostics and inpatient and outpatient case management. A change in diagnostic methods over the evaluation period, such as purely clinical or microscopy or rapid diagnostic test, can affect morbidity trends. In addition, health-care utilization trends and reporting rates can affect malaria morbidity and mortality calculations for health facilities. Because health-care utilization rates are low in most SSA malaria-endemic countries, only a potentially time-varying fraction of malaria deaths are likely to occur at public health facilities. Many malariarelated deaths occur at homes or at private facilities that do not link into HMIS. 1 Verbal autopsy is so far the only available and accessible method to measure malaria-specific mortality at the population level in a context where most deaths occur outside a formal health facilities. With verbal autopsy, the deceased's primary caregivers are interviewed for detailed information about events leading up to the death to ascertain and assign a cause. [22] [23] [24] [25] Existing verbal autopsy tools are not highly sensitive, 26 but efforts are underway to increase sensitivity in detecting cause of death, such as using computer-based algorithms and the simplified symptom pattern approach. 27 Although verbal autopsy may not provide a precise measure of malaria-specific mortality, it may give an idea of the ranking of malaria in a list of causes of death at to population level and help understand further malaria epidemiology. 28 In countries where such data exist, evaluations should consider exploring verbal autopsy for use in the plausibility assessment, particularly as a case study because the information in most cases is not available at the national level.
Civil registration and vital statistics systems are also potential data sources for measurement of population-level cause specific mortality. 29 However, in most countries data are not strong enough to use in impact evaluations at the national level, 30 a circumstance that could change as confirmation of malaria diagnosis with parasite density becomes more routine and medical autopsies are performed. 18 In the absence of reliable malaria-specific mortality data, and given the large indirect effects that malaria control interventions have on child health, 31 RBM and WHO recommend using all-cause under-five mortality as the standard impact measure in malaria-endemic countries. 17, 31, 32, 33 This is commonly measured through standardized national household surveys, such as DHS and MICS, in most malaria-endemic countries.
Contextual factors. Contextual factors that may influence outcome or impact indicators should be investigated for their potential contribution to changes in the outcomes of interest. Where possible, these contextual factors should be directly accounted for in the analytic framework used to assess the association between changes in malaria control intervention coverage and malaria health outcomes. Contextual factors can be divided into two groups, 1) distal (e.g., gross domestic product, housing condition, maternal education, and climate) and 2) proximal (e.g., nutritional status, childhood vaccination coverage, vitamin A supplementation, and breastfeeding). Fluctuation in contextual factors is expected, so evaluators should only look for anomalies that may explain changes in allcause under-five mortality, within the given the timeframe (Table 5) .
Data analysis. The primary method to build plausibility is to assess trends in malaria intervention coverage, malaria health outcomes, and potential contextual factors. An example is the Zanzibar North A district program evaluation that incorporated data from multiple sources, including HMIS-derived monthly incidence cases as the primary outcome, and explanatory variables, such as the year of program intervention and monthly rainfall from meteorological sources, all analyzed in a negative-binomial regression framework. 34 In another example from Zanzibar, evaluators used log-linear regression to assess reductions in malaria cases and deaths between the preintervention period of 1999-2003 and 2008. 35 Evaluators concluded that significant reductions in malaria cases and malaria-related mortality were made during the period evaluated.
Another example is the evaluation of the Bioko Island Malaria Control Project 36 in Equatorial Guinea that assessed 4 years of high-coverage scale-up of IRS, ITNs, and improved case management on the island. Researchers used survival regression to measure the change in all-cause mortality among children under 5 years of age. Calendar year was included as a covariate to test the presence of a declining trend in child mortality. Household access to electricity was included as a proxy indicator of household wealth. A subsample was used to test the association between rainfall in the previous 12 months and child mortality. Variables of interest included possession and use of ITNs, IRS coverage, and pregnant women protected through IPTp. As hypothesized, results indicated simultaneous drops in the prevalence of malaria parasite infection, anemia, reported fever, and allcause under-five mortality in children. This evaluation, however, did not include an in-depth discussion of contextual factors that could also have influenced the decline in all-cause under-five mortality.
The RBM impact evaluations, led by PMI, took advantage of a key strategy for data analysis: risk stratification. To strengthen the plausibility design, analyses of parasite prevalence, anemia prevalence, and mortality were stratified by age group, place of residence, and malaria risk zone, where data were available. 8 The stratification helped identify areas and subpopulations with the greatest potential to benefit from interventions and assess whether these groups experienced the highest reductions in morbidity or mortality during the evaluation. If reduction in anemia is associated with malaria decline, we would expect to see a higher baseline and greater reduction in severe anemia prevalence in areas with relatively higher malaria risk, considering that other factors remain constant. 37 Furthermore, if a major part of the decline in mortality among children under five was malaria related, we would expect a greater mortality decline among children under five living in areas of greater malaria risk, compared with areas of lower malaria risk, if other factors remain constant. 37, 38 In a similar way, we would expect a greater decline in mortality among the age group most likely to experience malaria-related death (6-24 months), compared with other childhood age groups, if malaria control interventions were the main mortality reduction driver. 39, 40 However, the age groups might change with the reduction of malaria infection. In countries where significant reduction have been achieved, it might be advisable to explore older age groups.
The results from such analyses to assess trends in malaria morbidity and mortality can be strengthened using further analytic methods tailored to the available data in a specific country. Building on previous work using a national-platform approach, where districts or district-time units formed the unit of analysis, [41] [42] [43] an available survey data analysis in Malawi used a Poisson model at the district level to examine the association between ITN coverage and all-cause child mortality. 12 In Uganda and Senegal, evaluators conducted a regression survival analysis to examine differences in child survival before and after the scale-up began. Separately, the analysis examined trends in variables, such as mother's education, DPT3 coverage, socioeconomic growth, access to health care, and temperature and rainfall anomalies. These types of analyses can be undertaken, depending on data availability and usefulness to the objectives of the evaluation itself.
Data may also be pooled across countries to provide evidence of malaria control intervention effects at the global level ( Figure 3) . 19, 43 After evaluations have been completed in several countries and comparable datasets are available, this kind of meta-analysis could provide more insight into malaria program effectiveness, especially where in-country analyses lack sufficient statistical power to detect program effects.
DISCUSSION
A consistent, accurate method is needed to evaluate the impact of the remarkable scale-up of malaria control interventions in SSA. Clear methods have yet to be identified to directly measure the impact of this scale-up, but this paper proposes an enhanced plausibility design.
The ability to attribute impact to interventions depends on the type of design. The gold standard to attribute causality is an experimental design because of the random assignment of units to intervention and control groups; however, this design is challenging for malaria control programs because intervention areas are based on nonrandom considerations and often are implemented at a national scale. Malaria control programs fall under the category of "complex intervention research," 4 with multiple interventions occurring simultaneously and interacting. In addition, interventions target various groups and sometimes require beneficiaries to adapt a number of behaviors to achieve the intended impact.
The impact evaluation design of malaria control intervention scale-up falls in the area of developing literature on complex or system-level interventions and plausibility evaluations. 4, 44 This literature suggests that, in addition to measuring changes in key indicators before and after an intervention, an evaluation should include four considerations: 1) a theoretical understanding of how the intervention causes change through an impact model; 2) allowance for variability in outcomes, depending on population characteristics, through the estimation of separate outcomes for different strata; 3) an assessment of the implementation process to determine if any lack of impact reflects implementation failure or genuine ineffectiveness, which can guide and improve program management; and 4) a thorough documentation of context to inform assessments about causality and help generalize results to other contexts.
The improved plausibility design proposed here builds on these principles. The design is advantageous in certain settings because it obviates the need for a control group, and it can assess the impact of national coverage programs. The success of this design, however, requires comprehensive and consistently high-quality data, as well as rigorous analytical techniques. Data from multiple sources in each country should be used to compensate for the shortcoming of any one method of data collection. For example, HMIS often underestimate the total deaths attributed to malaria because most malaria-related deaths in SSA occur outside of public health facilities; however, these data can be combined with confirmed-case reporting to more rigorously assess malaria control intervention impact. 40 Potential confounders should always be thoroughly investigated in trend analyses and other statistical models to evaluate the role of these factors on the health outcomes of interest.
Although the expanded evaluation framework provides a good basis for evaluating malaria control intervention impact, it does have some limitations. It is still unclear when or at what threshold of intervention coverage an impact evaluation becomes appropriate. The plausibility study design assumes that scale-up and its impact, along with contextual factors, can all be measured reliably at national and subnational levels; however, significant gaps still exist in data acquisition systems in most malaria-endemic countries. The proposed framework relies exclusively on secondary data and its application depends on the quality of the data. Therefore, additional efforts need to be put into strict data collection at the national and subnational levels.
Moreover, baseline data preceding the scale-up of malaria control interventions do not exist for many countries, making it difficult to measure change over time. Countries should continue to invest in strengthening routine health information system to ensure that periodic household surveys are complemented by robust longitudinal data from health facilities where malaria is diagnosed and treated. This is particularly important in changing malaria epidemiological context with countries moving from control to pre-elimination phase. As a starting point, a comprehensive mapping and cataloguing of routine health information systems data elements, data quality and data gaps will be helpful and serve as a baseline for improvement of the systems. Although similar mapping and catalogue exist for household surveys it is lacking for routine health information systems. Furthermore, baseline coverage levels will continue to shift as ongoing scale-up and maintenance of interventions affect malaria transmission and environmental changes alter malaria intensity. This new context will require changes in evaluation approaches and more reliable, flexible, timely, and representative systems for measuring changes in malaria control interventions and health outcomes.
It is also difficult to develop an accurate counterfactual scenario that captures a prescale-up level of intervention coverage and program intensity. If malaria was already in decline before scale-up, then continuation of prescale-up trends is a conservative or pessimistic counterfactual because this scenario must also assume that baseline coverage increases are also continuing. The program's contribution is then only the recent acceleration of coverage increases, without accounting for the past and current scale-up in coverage. On the other hand, if malaria had been on the rise before scale-up, assuming a continuation of that rise as counterfactual results in an optimistic estimation of impact. Malaria is an epidemic disease, and often a rise is followed by a decline, even without program effort. In addition, urbanization and socioeconomic development may be leading to declining secular trends in most countries.
The relationship between malaria coverage and impact has a time lag, and the dynamics of how burden trends respond to coverage trends is highly nonlinear. Malaria interventions may reach their full impact several years after coverage scale-up; however, that impact may include a partial rebound: as interventions reduce cases, people build up less acquired immunity, which can result in older age groups having a final new stabilized burden level that may not be as low as previous burden levels (e.g., the level 2 years after reaching maximum intervention coverage).
Despite all these challenges, the plausibility approach proposed in this paper provides a good avenue to document evidence of malaria control achievements in endemic countries. However, as data become more available and information systems are strengthened, further improvement to this approach will be needed.
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